Advertisement
The Scientist
The Scientist

News & Opinion

Covering the life sciences inside and out

Most Recent

Universal cancer vaccine being developed

By | August 31, 2000

Inhibiting the telomerase enzyme, present in most cancers, may prevent cell division but some scientists warn of "more harm than good."

0 Comments

BSE carriers may pass it on unknowingly

By | August 30, 2000

Sub-clinical infections in mice suggest that the food chain could be affected.

0 Comments

Ticked off the list

August 30, 2000

Botulinum toxin A injections provide relief from tics in patients with Tourette syndrome.

0 Comments

VEGF gene achieves angiogenesis

By | August 30, 2000

Vascular Endothelial Growth Factor restores blood flow to areas of cardiac tissue previously hibernating.

0 Comments

NEW YORK, Aug 28 (Praxis Press). Despite similar degrees of airflow obstruction, patients with past or present asthma, either with or without chronic obstructive pulmonary disease (COPD), walk more slowly than patients with COPD. Laszlo and colleagues studied twelve-minute walking speed (hurrying) and lung function in twenty-four patients with COPD, ten patients with asthma, four patients with both COPD and asthma, and eighteen healthy controls. Most of the difference (70%) in walking speeds bet

0 Comments

Anemia and pregnancy

August 29, 2000

Iron deficiency in women considering pregnancy should be corrected.

0 Comments

Estrogen and cognition

August 29, 2000

Free and unbound estrogen could protect older women from cognitive decline.

0 Comments

NIH issues US embryonic stem cell guidelines, at last

By | August 29, 2000

But November's presidential election is likely to determine whether US scientists will ever be able to do this work with taxpayer blessings - and money.

0 Comments

NEW YORK, Aug 28 (Praxis Press). Despite immunosuppressive and other therapies, the annual mortality rate of systemic lupus erythematosus (SLE) remains about one percent. Traynor and colleagues studied the effects of high-dose cyclophosphamide treatment and autologous, haematopoietic stem cell transplantation in nine patients with severe, steroid-dependent SLE. Two patients developed infections (cytomegalovirus and mucormycosis) after stem cell harvest and were excluded from the study; seven pat

0 Comments

Alcoholism treatment

August 25, 2000

NEW YORK, August 25 (Praxis Press). Early-onset alcoholism (before age 25 years) is associated with serotonergic dysfunction, and individuals with early-onset alcoholism may be responsive to treatment with a selective serotonergic agent. To compare the effectiveness of ondansetron, a selective serotonin receptor antagonist, in the treatment of early-onset and late-onset alcoholism, Johnson and colleagues performed a double blind, randomized, placebo-controlled clinical trial. A total of 321 pati

0 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Advertisement